3URP image
Entry Detail
PDB ID:
3URP
Keywords:
Title:
Re-refinement of PDB entry 5RNT - ribonuclease T1 with guanosine-3',5'-diphosphate and phosphate ion bound
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2011-11-22
Release Date:
2012-03-28
Method Details:
Experimental Method:
Resolution:
3.19 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
I 2 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Guanyl-specific ribonuclease T1
Chain IDs:A
Chain Length:104
Number of Molecules:1
Biological Source:Aspergillus oryzae
Primary Citation
Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER.
Acta Crystallogr.,Sect.D 68 368 380 (2012)
PMID: 22505257 DOI: 10.1107/S0907444911056058

Abstact

Maximum-likelihood X-ray macromolecular structure refinement in BUSTER has been extended with restraints facilitating the exploitation of structural similarity. The similarity can be between two or more chains within the structure being refined, thus favouring NCS, or to a distinct 'target' structure that remains fixed during refinement. The local structural similarity restraints (LSSR) approach considers all distances less than 5.5 Å between pairs of atoms in the chain to be restrained. For each, the difference from the distance between the corresponding atoms in the related chain is found. LSSR applies a restraint penalty on each difference. A functional form that reaches a plateau for large differences is used to avoid the restraints distorting parts of the structure that are not similar. Because LSSR are local, there is no need to separate out domains. Some restraint pruning is still necessary, but this has been automated. LSSR have been available to academic users of BUSTER since 2009 with the easy-to-use -autoncs and -target target.pdb options. The use of LSSR is illustrated in the re-refinement of PDB entries 5rnt, where -target enables the correct ligand-binding structure to be found, and 1osg, where -autoncs contributes to the location of an additional copy of the cyclic peptide ligand.

Legend

Protein

Chemical

Disease

Primary Citation of related structures